Influenza virus infections in cats

 

Updated July 2021a

 

These guidelines were published in J Feline Med Surg 2009; 11: 615-618 (Thiry et al., 2009). This completely new version was authored by Tadeusz Frymus et al and published in Viruses 13 (2021), 1435.

 

Key points

 

  • Domestic cats are susceptible to influenza virus infections from humans or animals, especially birds, which usually only induce subclinical infections or a mild fever.

 

  • Feline upper respiratory tract diseases caused by influenza viruses appear to be rare and usually self-limiting. Very rarely, in shelters or other crowded feline colonies, secondary bacterial infections may lead to pneumonia and fatalities.

 

  • Occasionally, the highly pathogenic influenza virus (H5N1) can be transmitted from poultry or wild birds to cats, and induce a severe, generalised disease with high fatality rate.

 

  • Detection by RT-PCR of viral RNA in nasal swabs can confirm influenza in a cat. In subclinical cases, a four-fold serum titre increase within 14 days indicates a recent infection.

 

  • In sick cats, routine isolation and quarantine procedures should be followed to prevent spreading, as cat-to-cat transmission of influenza may occur. If necessary, symptomatic medication, combined with the control of secondary bacterial infections, should be implemented.

 

  • There are no commercial vaccines against influenza for cats.

 

  • The risk of cat-to-human transmission of influenza is low. However, if highly pathogenic influenza viruses are found or suspected in a cat, all unnecessary contact should be minimised, and gloves, a mask and goggles should be used for protection.

 

Introduction

 

Influenza is a highly contagious, acute infection, usually of the upper respiratory tract, and has been detected worldwide in many vertebrate hosts (Krammer et al., 2018). Feline respiratory diseases caused by influenza viruses appear to be rather rare and usually self-limiting; however, secondary bacterial infections can lead to complications, and can be associated with fatalities. Very rarely, highly pathogenic influenza viruses can induce a severe, generalised viral disease with a high fatality rate in cats (Thiry et al., 2007).

 

Agent properties

 

The virus is a member of the Orthomyxoviridae family. Four types (A, B, C and D) of this agent are known. Influenza virus type A (IAV) is the most important and induces mass disease in humans worldwide, as well as animals, including birds, horses, pigs, minks, ferrets, bats and marine mammals. Dogs and cats may also be affected.

 

The IAV types are further classified as subtypes based on the antigenicity of the two viral surface proteins, haemagglutinin (H) and neuraminidase (N). There are 16 H and 9 N antigens (Krammer et al., 2018), and their different combinations result in 144 IAV subtypes (e.g., H1N1, H3N8, H5N2 etc.). In addition, further subtypes (H17N10 and H18N11) of influenza-like viruses have been found in bats, but they appear to be distinct from conventional IAVs in multiple aspects (Yang et al., 2021).

 

Influenza viruses are genetically highly variable, rapidly changing their antigens, virulence, and ability to replicate in novel host species (Wille and Holmes, 2020). Two mechanisms are responsible for this: genetic drift and genetic shift. Genetic drift results from mutations in the genes encoding N or H, producing a new antigenic variant of a given subtype. If replication of such a variant is less effectively inhibited by the host immunity that eliminated the infection caused by the original strain, the mutated virus can infect the same population again. In contrast, antigenic shift leads to the sudden emergence of a new subtype resulting from the exchange (reassortment) of RNA fragments between 2 or more IAV subtypes replicating at the same time in a host (Wille and Holmes, 2020). Well recognized “mixing vessel” hosts for human IAVs are pigs and birds, but recent data suggest that also dogs and cats might potentially play such a role (Chen et al., 2018; Zhao S et al., 2020). These new subtypes, that share pathogenic properties with their parental lineages and have a mixture of the surface antigens of the original strains, can be highly dangerous. As the target host population is often immunologically naïve to the new subtype, epidemics, or even pandemics, in different animal species and humans have arisen in the past (Krammer et al., 2018). Due to further selection pressure (genetic drift) a new subtype can evolve into multiple antigenic variants, grouped into sublineages or clades (He et al., 2019). All these genetic variability mechanisms contribute to the permanent circulation of IAVs in avian and mammalian populations.

 

Influenza viruses are quickly inactivated by UV-light, detergents and disinfectants. However, in water IAV remains infectious for weeks to months depending on pH, salinity, and temperature (Irwin et al., 2011; Keeler et al., 2012).

 

Circulation of IAVs

 

Among the possible 144 IAV subtypes, the vast majority have been found in waterfowl (especially ducks, geese, and swans), their natural host (Sonnberg et al., 2013). Birds, which are often subclinically infected, can also shed IAVs in their faeces, and their seasonal migrations are crucial for the circulation of IAVs worldwide (Fig. 1). The virus can overwinter in ice (e.g., that of northern lakes), which allows for the re-emergence of influenza in the following season.

 

Fig. 1. Emergence and transmission of influenza A viruses from aquatic wild bird reservoirs (adapted from Krammer et al., 2018).

 

Generally, IAVs isolated from a given species are able to replicate effectively in this host. Thus, the terms “human strains”, “avian strains”, “equine strains” etc. are commonly used. However, their high genetic variability facilitates adaptation to other host species, inducing “novel” influenza outbreaks in them. Examples of this include the well-documented epidemics of human influenza that emerged from pigs (Krammer et al., 2018), the canine outbreaks induced by equine H3N8 IAV (Crawford et al., 2005; Crawford et al., 2011), and, in particular, several outbreaks that were generated by avian IAVs in different mammalian species, including dogs and cats (Song et al., 2008; Newbury et al., 2017).

 

On the other hand, variability allows not only the emergence of new viral strains, but also the disappearance of established ones, such as equine H7N7 IAV, that has not been isolated from horses since 1979 (Webster, 1993), or canine H3N8 IAV, that circulated continuously among dogs in the USA for 15 years, but has only been found on rare occasions since 2016 (Wille and Holmes, 2020).

 

Pathogenesis

 

Most IAV induce acute upper respiratory tract infections that are either self-limiting or subclinical (Krammer et al., 2018). Though secondary bacterial infections or other complications may result from IAV infection, these agents are called “low pathogenic strains”. In humans, horses, pigs, dogs and some other species, they replicate only in the upper respiratory tract, inducing the common “seasonal” flu. After an incubation period of 1 to a few days, inflammation of the bronchial mucosa leads to necrotic lesions, exudate, and lung hyperaemia. Most cases recover after 1 to 3 weeks but, in some, bacterial complications can result in pneumonia; this occurs particularly in poor conditions, as a result of stress, in the very young as well as the old. The fatality rate is <1% in most infections (Wasik et al., 2021). A natural feline disease of this type has very rarely been seen (Song et al., 2011; Fiorentini et al., 2011; Jeoung et al., 2013). Experimental infection of cats with low pathogenic IAVs hardly ever induce disease, but subclinical replication usually occurs for a few days (Paniker and Nair, 1970; Romváry et al., 1975; Hinshaw et al., 1981).

 

In contrast, appearing mostly in birds, highly pathogenic IAVs are able to replicate not only in the respiratory tract, but also in the gastrointestinal tract, muscles, heart, brain and other organs resulting in acute, systemic disease that is often associated with a high fatality rate. These IAVs induce sudden, mass mortality in chickens, turkeys and other fowl, but subclinical infections are also common in wild birds. In mammals, this type of influenza is very rare. However, in 1918-1920 the worldwide human “Spanish flu” pandemic, with an estimated 20-40 million deaths, was caused by a highly pathogenic H1N1 IAV.

 

The highly pathogenic avian H5N1 IAV can also induce severe generalized disease in cats after an incubation period of 1-2 days (Kuiken et al., 2004). Virus shedding via the respiratory tract and in faeces starts by day 3 post infection and persists for 4 days or longer (Rimmelzwaan et al., 2006). After oral, and possibly also respiratory infection, replication begins most probably in the gastrointestinal and/or upper respiratory tracts, and then in the lungs, resulting in foci of alveolar damage (van Riel et al., 2006). The virus eventually reaches the liver, heart, brain, renal glomeruli, adrenal cortex, and sometimes the spleen, pancreas, and large intestine (Rimmelzwaan et al., 2006; Songserm et al., 2006; Yingst et al., 2006). In some domestic cats or wild felids, non-suppurative encephalitis and ganglio-neuritis of the intestinal plexus nervosus were observed (Keawcharoen et al., 2004; Rimmelzwaan et al., 2006). Multifocal haemorrhages and necroses in different organs and bronchointerstitial pneumonia are responsible for acute mortality (Reperant et al., 2012).

 

Epidemiology of IAV infections in cats

 

For a long time, it was believed that cats were resistant to influenza. Today, it is clear, that cats, dogs, ferrets and other carnivores are involved in the worldwide circulation of IAVs (Wasik et al., 2021).

 

Low pathogenic IAVs

 

Early experiments revealed that cats are susceptible to some IAVs isolated from humans, birds and seals which usually only induce subclinical infections or mild fever (Paniker and Nair, 1970; Romváry et al., 1975; Hinshaw et al., 1981).

 

Additionally, canine IAV can occasionally be transmitted to cats. The first outbreak of severe influenza in dogs occurred in 2002 in English foxhounds and was caused by equine H3N8 IAV (Daly et al., 2008). Serological studies revealed that this agent, adapted to dogs as canine IAV, was circulating among racing greyhounds in the USA from the early 2000s (Anderson et al., 2012). After an outbreak in Florida, this virus spread to other breeds and regions of the USA, particularly to shelters (Crawford et al., 2005; Payungporn et al., 2008; Rivailler et al., 2010). Another cross-species transmission of the H3N8 IAV to dogs was documented during an epidemic of equine influenza in Australia 2007 (Crawford et al., 2011). Natural equine H3N8 IAV infection has not been found in cats so far, but after experimental inoculation, cats do develop the disease, shed the virus, and transmit the infection to other cats via contact (Su et al., 2014).

 

In South Korea and China, around 2004-2005, a H3N2 IAV emerged in dogs, most probably of avian origin, and became enzootic there (Song et al., 2008; Zhu et al., 2015). Since 2015, this agent has been repeatedly introduced to the USA and Canada by dogs rescued from Asian meat production farms, resulting in several outbreaks (Voorhees et al., 2017; Wasik et al., 2021). Cross-species transmission of this virus is possible as, after experimental inoculations, ferrets, guinea pigs and also cats have been infected (Kim et al., 2013). Furthermore, natural feline outbreaks with fever, tachypnea, sneezing, coughing, dyspnoea and lethargy were noted in 2 shelters (Song et al., 2011; Jeoung et al., 2013). In one of these shelters, the morbidity rate was 100% and mortality rate was 40%. Though cats can be infected via direct dog-to-cat or cat-to-cat transfer, this virus obviously replicates less efficiently in cats than in dogs, as natural feline outbreaks appear to be very rare. Such outbreaks were largely confined to shelters, and the virus does not appear to undergo pro­longed transmission in household cats (Voorhees et al., 2017).

 

From 2016 to 2017, an avian H7N2 IAV infected cats in a New York shelter, and quickly spread to other shelters in New York and Pennsylvania, likely via the movement of cats between the shelters (Newbury et al., 2017; Blachere et al., 2018). The virus was easily transmitted between cats, but not among dogs, chickens, or rabbits housed in the same facilities (Lee et al., 2017). In total, approximately 500 cats were found to be infected and most experienced mild respiratory ill­ness (Hatta et al., 2018). One el­derly cat with underlying conditions developed severe pneumonia and was eu­thanised. Additionally, a veterinarian and a shelter worker, both of whom had multiple direct periods of exposure to the cats without using personal protective equipment, became infected and exhibited mild, transient respiratory disease (Belser et al., 2017).

 

Experimental inoculations confirmed that cats were susceptible to the human H3N2 IAV that induced the “Hong-Kong” influenza pandemic in 1968 (Paniker and Nair, 1970). Furthermore, several studies indicated that, in 2009, cats (and dogs) worldwide could be infected by the H1N1 IAV during the subsequent human influenza pandemic, probably by direct transmission from their owners (Löhr et al., 2010; Sponseller et al., 2010; Ali et al., 2011; Campagnolo et al., 2011; Pigott et al., 2014; Zhao FR et al., 2014; Tangwangvivat et al., 2019; Zhao S et al., 2020). In Italy, this virus caused an outbreak of respiratory and gastrointestinal disease in a colony of 90 cats, resulting in 25 deaths (Fiorentini et al., 2011). Cat-to-cat transmission was suspected (van den Brand et al., 2010; Fiorentini et al., 2011).

 

There are also reports of occasional influenza cases in cats caused by other IAVs (Cao et al., 2017; Borland et al., 2020; Wasik et al., 2021). A recent study confirmed that the presence of antibodies to IAVs of both avian and human origin is not uncommon in European shelter cats (Zhao S et al., 2020). Antibodies against H1, H3, H5, H7 and H9 were found in their sera.

 

Highly pathogenic H5N1 IAV

 

In Asia, a highly pathogenic strain H5N1 IAV emerged in 1996, which caused a substantial epidemic of “avian flu” with a high mortality rate in poultry at the beginning of the 21st century. Hundreds of millions of poultry were destroyed (Webster et al., 2005). Mammals were sporadically affected, including over 860 humans, with a fatality rate of more than 50% (World Health Organization, 2020). Severe cases in domestic cats were also noted (Kuiken et al., 2004; Thiry et al., 2007), as well as in wild felids (Keawcharoen et al., 2004) that were fed, or had other contact with, infected chickens. In one outbreak, tiger-to-tiger transmission was suspected (Thanawongnuwech et al., 2005). As this epidemic reached Europe and Africa, incidental feline cases were also seen there (Thiry et al., 2007) as well as subclinical infections (Leschnik et al., 2007). Usually, these were connected to infected wild birds or poultry. Nevertheless, even in areas in which birds are infected with H5N1 IAV, cats are rarely positive by serology or PCR (Marschall et al., 2008; Zhao FR et al., 2015). Experimental infections have confirmed that the highly pathogenic H5N1 IAV may induce a severe, fatal disease in domestic cats, and can spread via cat-to-cat contact (Kuiken et al., 2004; Rimmelzwaan et al., 2006; Vahlenkamp et al., 2008). The virus is excreted not only via the respiratory tract, but also in faeces. It should be stressed that the highly pathogenic H5N1 IAV is still circulating in many parts of the world, including Europe. In the first half of 2021, several outbreaks in wild birds or poultry were noted in Finland, Germany, Denmark, Slovakia, Hungary, France, Latvia, and Estonia (ProMED-mail, 2021).

 

In summary, the data presented above clearly show that domestic cats are susceptible to natural IAV infections from other species. They result most likely from close contact with infected humans or animals, especially birds. Serological surveys suggest low to moderate rates of seroconversion to low pathogenic seasonal human or animal strains, and sporadic seroconversions to highly pathogenic avian strains. However, IAVs appear to spread inefficiently among feline populations, probably due to their social organisation, that limits the direct cat-to-cat contact that is required for viral transmission. So far, feline influenza epidemics have not been recorded, with only rare outbreaks in dense populations such as shelters. Therefore, cats are not considered a reservoir of influenza. In contrast to humans, horses, pigs, bats, dogs and some other species, adaptation of IAVs to feline hosts has not yet occurred.

 

Clinical signs

 

Low pathogenic IAVs usually only induce a subclinical infection or mild, self-limiting upper respiratory tract disease with sneezing as well nasal and/or ocular discharge in cats. Very rarely, in shelters or other crowded colonies, secondary bacterial infections may lead to pneumonia, manifesting as a rise in body temperature, tachypnoea, dyspnoea, coughing, lethargy, and fatalities (Fiorentini et al., 2011; Song et al., 2011; Jeoung et al., 2013; Hatta et al., 2018).

 

Though subclinical infection is also possible, highly pathogenic avian H5N1 IAV in cats usually induces severe clinical signs, including a high fever from day 1 post infection and, by day 2, lethargy, protrusion of the nictitating membranes, conjunctivitis, dyspnoea and a high fatality rate. If diffuse haemorrhagic lesions occur, some cats show serosanguinuous nasal discharge and icterus. Convulsions, ataxia or other neurological signs, as well as gastrointestinal symptoms, can also be seen (Kuiken et al., 2004; Thanawongnuwech et al., 2005; Rimmelzwaan et al., 2006; Songserm et al., 2006; Vahlenkamp et al., 2008).

 

Pathological lesions

 

In cats that died due to low pathogenic human H1N1 IAV infection, histological examinations revealed bronchointerstitial pneumonia, epithelial bronchiolar hyperplasia and alveolar necrosis (Fiorentini et al., 2011; Pigott et al., 2014; Knight et al., 2016).

 

The necropsy of domestic cats or wild felids infected by the highly pathogenic H5N1 IAV showed multifocal pulmonary lesions and petechial haemorrhages in the lungs, heart, thymus, stomach, intestine, tonsils, mandibular and retropharyngeal lymph nodes and liver, as well as a haemorrhagic pancreatitis (Keawcharoen et al., 2004; Yingst et al., 2006). Microscopically, these were inflammatory and necrotic lesions.

 

Diagnosis

 

In cats showing signs of acute upper respiratory tract inflammation, influenza should be considered if other etiological agents, such as feline herpesvirus and calicivirus, have been excluded. Risk factors include being in a shelter and close contact with humans or animals suffering from influenza. This applies especially when severe acute respiratory disease is seen in a cat that has outdoor access during an outbreak of highly pathogenic avian influenza infections in poultry and/or aquatic wild birds in the region (Thiry et al., 2007).

 

Detection of the infectious agent

 

IAVs can be isolated in tissue culture or embryonated eggs from nasal or oropharyngeal swabs, or during a post-mortem examination from pulmonary tissue (and, in the case of highly pathogenic strains, from rectal swabs or faecal samples, affected organs, intestinal content and pleural fluid).

 

Viral RNA can be detected in nasal swabs by reverse-transcription PCR during the first 4 days of infection.

 

For dogs and some other animal species, commercial point-of-care tests are offered for the quick detection of IAV antigens in nasal swabs. These assays have not been validated for cats so far.

 

Detection of antibodies

 

In subclinical cases, serology (haemagglutination inhibition test or neutralisation assays) may be useful for the detection of antibodies. A four-fold serum titre increase within 14 days indicates a recent IAV infection. A comparison of serological assays during a screening study for IAV antibodies in cats has been published recently (Zhao S et al., 2020).

 

Treatment

 

The upper respiratory tract disease that occurs as a result is usually mild and self-limiting. In rare, complicated cases, symptomatic medication, combined with the control of secondary bacterial infections, should be implemented alongside other procedures used in cats suffering from other acute viral upper respiratory diseases. In humans, oseltamivir is commonly used for the treatment or prevention of IAV infections. This antiviral drug has been given to healthy tigers at risk of highly pathogenic H5N1 IAV infection, but there was no evidence of protection (Thanawongnuwech et al., 2005).

 

Vaccination

 

Though it has been shown that a heterologous avian H5N6 IAV vaccine can protect cats against lethal challenge with the highly pathogenic H5N1 IAV (Vahlenkamp et al., 2008), no commercial vaccines for cats are available at present.

 

Recently, it was shown that a commercial inactivated H3N2 canine IAV vaccine was well tolerated and induced seroconversion in cats (Velineni et al., 2020). Even if this vaccine was to be licensed for cats, its usage in Europe is not recommended as this virus has been never detected in Europe, and in regions with canine influenza outbreaks infections in cats are very rare.

 

Prevention

 

In the case of an influenza outbreak in a cattery, routine isolation and quarantine procedures should be followed to prevent the spread, as cat-to-cat transmission may occur.

 

Any contact of cats with poultry or wild birds infected by H5N1 or other highly pathogenic IAVs should be prevented. The European Commission has therefore recommended to keep cats indoors in areas in which outbreaks of H5N1 IAV infections are recorded in poultry or wild birds (Council of the European Union, 2006).

 

Zoonotic risk

 

Cats are not considered a reservoir of IAVs. To date, cats infected by both low as well as highly pathogenic IAVs appear to be dead-end host species (Harder and Vahlenkamp, 2010). Only two cases of cat-to-human transmission of a low pathogenic avian H7N2 IAV have been documented so far (Belser et al., 2017; Borland et al., 2020). These cases occurred in a shelter after teh prolonged and unprotected exposure of a veterinarian and a worker to ill cats and their respiratory secretions, which indicates that the risk of cat-to-human transmission is low (Lee et al., 2017). On the contrary, infected humans can be the source of feline infections with seasonal IAVs.

 

Although cats are sensitive to the highly pathogenic avian H5N1 IAV that caused over 860 human cases worldwide, not one human case was derived from cats. Nevertheless, if highly pathogenic IAVs are found or suspected in a cat, the risk of transmission to humans should be reduced by wearing gloves, a mask and goggles, minimising all unnecessary contact, and carrying out disinfection procedures (Thiry et al., 2007).

 

Acknowledgement

 

ABCD Europe gratefully acknowledges the support of Boehringer Ingelheim (the founding sponsor of the ABCD) and Virbac.

 

Many thanks to Karin de Lange for providing Figure 1.

 

References

 

Ali A, Daniels JB, Zhang Y, et al (2011): Pandemic and seasonal human influenza virus infections in domestic cats: prevalence, association with respiratory disease, and seasonality patterns. J Clin Microbiol 49(12), 4101-4105. doi:10.1128/JCM.05415-11

 

Anderson TC, Bromfield CR, Crawford PC, Dodds WJ, Gibbs EP, Hernandez JA (2012): Serological evidence of H3N8 canine influenza-like virus circulation in USA dogs prior to 2004. Vet J 191, 312–316.

 

Belser JA, Pulit-Penaloza JA, Sun X, et al (2017): A Novel A(H7N2) Influenza Virus Isolated from a Veterinarian Caring for Cats in a New York City Animal Shelter Causes Mild Disease and Transmits Poorly in the Ferret Model. J Virol 91(15), e00672-17. Published 2017 Jul 12. doi:10.1128/JVI.00672-17.

 

Blachere FM, Lindsley WG, Weber AM, et al (2018): Detection of an avian lineage influenza A(H7N2) virus in air and surface samples at a New York City feline quarantine facility. Influenza Other Respir Viruses 12(5), 613-622. doi:10.1111/irv.12572

 

Borland S, Gracieux P, Jones M, Mallet F, Yugueros-Marcos J (2020): Influenza A Virus Infection in Cats and Dogs: A Literature Review in the Light of the "One Health" Concept. Front Public Health 8, 83. Published 2020 Mar 20. doi:10.3389/fpubh.2020.00083

 

Campagnolo ER, Rankin JT, Daverio SA, et al (2011): Fatal pandemic (H1N1) 2009 influenza A virus infection in a Pennsylvania domestic cat. Zoonoses Public Health 58(7), 500-507. doi:10.1111/j.1863-2378.2011.01390.x

 

Cao X, Yang F, Wu H, Xu L (2017): Genetic characterization of novel reassortant H5N6-subtype influenza viruses isolated from cats in eastern China. Arch Virol 162(11), 3501-3505. doi:10.1007/s00705-017-3490-2

 

Chen Y, Trovão NS, Wang G, et al (2018): Emergence and Evolution of Novel Reassortant Influenza A Viruses in Canines in Southern China. mBio 9(3), e00909-18. Published 2018 Jun 5. doi:10.1128/mBio.00909-18.

 

Council of the European Union (2006): Council Directive 2005/94/EC of 20 December 2005 on Community Measures for the Control of Avian Influenza and Repealing Directive 92/40/EEC. Official Journal of the European Union 14 January 2006, L 10/16–L 10/65.

 

Crawford PC, Dubovi EJ, Castleman WL, et al (2005): Transmission of equine influenza virus to dogs. Science 310(5747), 482-485. doi:10.1126/science.1117950

 

Crawford PC, Dubovi EJ, Castleman WL, Stephenson I, Gibbs EP, Chen L, Smith C, Hill RC, Ferro P, Pompey J, Bright RA, Medina MJ, Johnson CM, Olsen CW, Cox NJ, Klimov AI, Crispe E, Finlaison DS, Hurt AC, Kirkland PD (2011): Infection of dogs with equine influenza virus: evidence for transmission from horses during the Australian outbreak. Aust Vet J 89, 27–28. doi:10.1111/j.1751-0813.2011.00734.x

 

Daly JM, Blunden AS, Macrae S, Miller J, Bowman SJ, Kolodziejek J, Nowotny N, Smith KC (2008): Transmission of equine influenza virus to English foxhounds. Emerg Infect Dis 14, 461–464.

 

Fiorentini L, Taddei R, Moreno A, et al (2011): Influenza A pandemic (H1N1) 2009 virus outbreak in a cat colony in Italy. Zoonoses Public Health 58(8), 573-581. doi:10.1111/j.1863-2378.2011.01406.x

 

Harder TC, Vahlenkamp TW (2010): Influenza virus infections in dogs and cats. Vet Immunol Immunopathol 134(1-2), 54-60. doi:10.1016/j.vetimm.2009.10.009

 

Hatta M, Zhong G, Gao Y, et al (2018): Characterization of a Feline Influenza A(H7N2) Virus. Emerg Infect Dis 24(1), 75-86. doi:10.3201/eid2401.171240

 

He W, Li G, Wang R, Shi W, Li K, Wang S, Lai A, Su S (2019): Host-range shift of H3N8 canine influenza virus: a phylodynamic analysis of its origin and adaptation from equine to canine host. Vet Res 50(1), 87. doi: 10.1186/s13567-019-0707-2

 

Hinshaw VS, Webster RG, Easterday BC, Bean WJ Jr (1981): Replication of avian influenza A viruses in mammals. Infect Immun 34(2), 354-361.

 

Irwin CK, Yoon KJ, Wang C, Hoff SJ, Zimmerman JJ, Denagamage T, O'Connor AM (2011): Using the systematic review methodology to evaluate factors that influence the persistence of influenza virus in environmental matrices. Applied and environmental microbiology 77(3), 1049–1060. https://doi.org/10.1128/AEM.02733-09

 

Jeoung HY, Lim SI, Shin BH, et al (2013): A novel canine influenza H3N2 virus isolated from cats in an animal shelter. Vet Microbiol 165, 281–286.

 

Keawcharoen J, Oraveerakul K, Kuiken T, Fouchier RAM, Amonsin A, Payungporn S, Noppornpanth S, Wattanodorn S, Theambooniers A, Tantilertcharoen R, et al (2004): Avian influenza H5N1 in tigers and leopards. Emerging Infect Dis 10, 2189–2191. doi:10.3201/eid1012.040759

 

Keeler SP, Berghaus RD, Stallknecht DE (2012): Persistence of low pathogenic avian influenza viruses in filtered surface water from waterfowl habitats in Georgia, USA. J Wildl Dis 48(4), 999-1009. doi:10.7589/2011-11-314

 

Kim H, Song D, Moon H, et al (2013): Inter- and intraspecies transmission of canine influenza virus (H3N2) in dogs, cats, and ferrets. Influenza Other Respir Viruses 7(3), 265-270. doi:10.1111/j.1750-2659.2012.00379.x

 

Knight CG, Davies JL, Joseph T, Ondrich S, Rosa BV (2016): Pandemic H1N1 influenza virus infection in a Canadian cat. Can Vet J 57(5), 497-500.

 

Krammer F, Smith GJD, Fouchier RAM, Peiris M, Kedzierska K, Doherty PC, Palese P, Shaw ML, Treanor J, Webster RG, García-Sastre A (2018): Influenza. Nat Rev Dis Primers 4(1), 3. doi: 10.1038/s41572-018-0002-y.

 

Kuiken T, Rimmelzwaan G, van Riel D, et al (2004): Avian H5N1 influenza in cats. Science 306(5694), 241. doi:10.1126/science.1102287

 

Lee CT, Slavinski S, Schiff C, et al (2017): Outbreak of Influenza A(H7N2) Among Cats in an Animal Shelter With Cat-to-Human Transmission-New York City, 2016. Clin Infect Dis 65(11), 1927-1929. doi:10.1093/cid/cix668

 

Leschnik M, Weikel J, Möstl K, Revilla-Fernández S, Wodak E, Bagó Z, Vanek E, Benetka V, Hess M, Thalhammer JG (2007): Subclinical infection with avian influenza A (H5N1) virus in cats. Emerging Infect Dis 13, 243–247. doi:10.3201/eid1302.060608

 

Löhr CV, DeBess EE, Baker RJ, et al (2010): Pathology and viral antigen distribution of lethal pneumonia in domestic cats due to pandemic (H1N1) 2009 influenza A virus. Vet Pathol 47(3), 378-386. doi:10.1177/0300985810368393

 

Marschall J, Schulz B, Harder TC, et al (2008): Prevalence of influenza A H5N1 virus in cats from areas with occurrence of highly pathogenic avian influenza in birds. J Feline Med Surg 10(4), 355-358. doi:10.1016/j.jfms.2008.03.007.

 

Newbury SP, Cigel F, Killian ML, Leutenegger CM, Seguin MA, Crossley B, Brennen R, Suarez DL, Torchetti M, Toohey-Kurth K (2017): First Detection of Avian Lineage H7N2 in Felis catus. Genome announcements 5(23), e00457-17. https://doi.org/10.1128/genomeA.00457-17

 

Paniker CK, Nair CM (1970): Infection with A2 Hong Kong influenza virus in domestic cats. Bull World Health Organ 43(6), 859–862.

 

Payungporn S, Crawford PC, Kouo TS, Chen LM, Pompey J, Castleman WL, Dubovi EJ, Katz JM, Donis RO (2008): Influenza A virus (H3N8) in dogs with respiratory disease, Florida. Emerg Infect Dis 14, 902–908.

 

Pigott AM, Haak CE, Breshears MA, Linklater AK (2014): Acute bronchointerstitial pneumonia in two indoor cats exposed to the H1N1 influenza virus. J Vet Emerg Crit Care 24, 715–723.

 

ProMED-mail (2021). PRO/AH/EDR> Avian Influenza (82): Europe (Germany, Estonia) Wild Bird, HPAI H5N1, OIE. Available online: https://promedmail.org/promed-post/?id=8446706 (accessed on 16 June 2021).

 

Reperant LA, van de Bildt MWG, van Amerongen G, Leijten LME, Watson S, Palser A, Kellam P, Eissens AC, Frijlink HW, Osterhaus ADME, et al (2012): Marked endotheliotropism of highly pathogenic avian influenza virus H5N1 following intestinal inoculation in cats. J Virol 86, 1158–1165. doi:10.1128/JVI.06375-11

 

Rimmelzwaan GF, van Riel D, Baars M, Bestebroer TM, van Amerongen G, Fouchier RAM, Osterhaus ADME, Kuiken T (2006): Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am J Pathol 168, 176–183. doi:10.2353/ajpath.2006.050466

 

Rivailler P, Perry IA, Jang Y, Davis CT, Chen LM, Dubovi EJ, Donis RO (2010): Evolution of canine and equine influenza (H3N8) viruses co-circulating between 2005 and 2008. Virology 408, 71–79.

 

Romváry J, Rózsa J, Farkas E (1975): Infection of dogs and cats with the Hong Kong influenza A (H3N2) virus during an epidemic period in Hungary. Acta Vet Acad Sci Hung 25(2-3), 255-259.

 

Song DS, An DJ, Moon HJ, et al (2011): Interspecies transmission of the canine influenza H3N2 virus to domestic cats in South Korea. J Gen Virol 92, 2350–2355.

 

Song D, Kang B, Lee C, et al (2008): Transmission of avian influenza virus (H3N2) to dogs. Emerg Infect Dis 14(5), 741-746. doi:10.3201/eid1405.071471

 

Songserm T, Amonsin A, Jam-on R, et al (2006): Avian influenza H5N1 in naturally infected domestic cat. Emerg Infect Dis 12(4), 681-683. doi:10.3201/eid1204.051396

 

Sonnberg S, Webby RJ, Webster RG (2013): Natural history of highly pathogenic avian influenza H5N1. Virus Res 178(1), 63-77. doi: 10.1016/j.virusres.2013.05.009.

 

Sponseller BA, Strait E, Jergens A, et al (2010) : Influenza A pandemic (H1N1) 2009 virus infection in domestic cat. Emerg Infect Dis 16(3), 534-537. doi:10.3201/eid1603.091737

 

Su S, Wang L, Fu X, et al (2014): Equine influenza A(H3N8) virus infection in cats. Emerg Infect Dis 20(12), 2096-2099. doi:10.3201/eid2012.140867

 

Tangwangvivat R, Chanvatik S, Charoenkul K, Chaiyawong S, Janethanakit T, Tuanudom R, Prakairungnamthip D, Boonyapisitsopa S, Bunpapong N, Amonsin A (2019): Evidence of pandemic H1N1 influenza exposure in dogs and cats, Thailand: A serological survey. Zoonoses Public Health 66, 349–353.

 

Thanawongnuwech R, Amonsin A, Tantilertcharoen R, Damrongwatanapokin S, Theamboonlers A, Payungporn S, Nanthapornphiphat K, Ratanamungklanon S, Tunak E, Songserm T, et al (2005): Probable tiger-to-tiger transmission of avian influenza H5N1. Emerging Infect Dis 11, 699–701. doi:10.3201/eid1105.050007

 

Thiry E, Zicola A, Addie D, et al (2007): Highly pathogenic avian influenza H5N1 virus in cats and other carnivores. Vet Microbiol 122(1-2), 25-31. doi:10.1016/j.vetmic.2006.12.021

 

Vahlenkamp TW, Harder TC, Giese M, et al (2008): Protection of cats against lethal influenza H5N1 challenge infection. J Gen Virol 89(Pt 4), 968-974. doi:10.1099/vir.0.83552-0

 

van den Brand JM, Stittelaar KJ, van Amerongen G, et al (2010): Experimental pandemic (H1N1) 2009 virus infection of cats. Emerg Infect Dis 16(11), 1745-1747. doi:10.3201/eid1611.100845

 

van Riel D, Munster VJ, de Wit E, et al (2006): H5N1 Virus Attachment to Lower Respiratory Tract. Science 312(5772), 399. doi:10.1126/science.1125548

 

Velineni S, Hainer N, Conlee D, Hutchinson K (2020): Vaccination with an inactivated canine influenza H3N2 virus vaccine is safe and elicits an immune response in cats. J Feline Med Surg 22(2), 199-202. doi:10.1177/1098612X19833261

 

Voorhees IEH, Glaser AL, Toohey-Kurth KL, et al (2017): Spread of canine influenza A (H3N2) virus, United States. Emerg Infect Dis 23, 1950–1957.

 

Wasik BR, Voorhees IEH, Parrish CR (2021): Canine and feline influenza. Cold Spring Harb Perspect Med 11, a038562.

 

Webster RG (1993): Are equine 1 influenza viruses still present in horses? Equine Vet J 25(6), 537-538. doi:10.1111/j.2042-3306.1993.tb03009.x

 

Webster RG, Guan Y, Poon L, Krauss S, Webby R, Govorkovai E, Peiris M (2005): The spread of the H5N1 bird flu epidemic in Asia in 2004. Arch Virol Suppl 19, 17–29.

 

Wille M, Holmes EC (2020): The ecology and evolution of influenza viruses. Cold Spring Harb Perspect Med 10, a038489.

 

World Health Organization (2020): https://www.who.int/influenza/human_animal_interface/2020_10_07_tableH5N1.pdf?ua=1)

 

Yang W, Schountz T, Ma W (2021): Bat influenza viruses: Current status and perspective. Viruses 13, 547.

 

Yingst SL, Saad MD, Felt SA (2006): Qinghai-like H5N1 from domestic cats, northern Iraq. Emerg Infect Dis 12(8), 1295-1297. doi:10.3201/eid1708.060264

 

Zhao FR, Liu CG, Yin X, Zhou DH, Wei P, Chang HY (2014): Serological report of pandemic (H1N1) 2009 infection among cats in northeastern China in 2012-02 and 2013-03. Virol J 11, 49. Published 2014 Mar 14. doi:10.1186/1743-422X-11-49

 

Zhao FR, Zhou DH, Zhang YG, et al (2015): Detection prevalence of H5N1 avian influenza virus among stray cats in eastern China. J Med Virol 87(8), 1436-1440. doi:10.1002/jmv.24216

 

Zhao S, Schuurman N, Tieke M, Quist B, Zwinkels S, van Kuppeveld F, de Haan CAM, Egberink H (2020): Serological screening of influenza A virus antibodies in cats and dogs indicates frequent infection with different subtypes. J Clin Microbiol JCM.01689-20. doi: 10.1128/JCM.01689-20. Epub ahead of print. PMID: 32878956.

 

Zhu H, Hughes J, Murcia PR (2015): Origins and evolutionary dynamics of H3N2 canine influenza virus. J Virol 89, 5406–5418. doi:10.1128/JVI.03395-14

Back to Top